Ocrevus | 合法藥品大搜索

2016年7月4日 — ocrelizumab MAA和BLA的提交，是基於3項III期臨床研究的積極數據，這些研究均達到了主要終點和關鍵次要終點。在RMS患者中開展的2項III期 ... Read More

Ocrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal​ ... Read More

Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for​ ... Read More

Medscape - Multiple sclerosis dosing for Ocrevus (ocrelizumab), frequency-​based adverse effects, comprehensive interactions, contraindications, pregnancy​ ... Read More

Other names: Ocrevus Ocrelizumab is an experimental drug which is being developed as a treatment for relapsing remitting and primary progressive MS. Read More

Ocrevus (ocrelizumab). ocrevus-740. Ocrevus is a medicine that represents a different scientific approach to treating multiple sclerosis. It targets a type of ... Read More

Ocrelizumab is a drug that, since early 2018, has a Europe-wide licence to treat relapsing MS and early primary progressive MS. Its brand name is Ocrevus. Read More

Ocrevus. ocrelizumab ... ocrelizumab. International non-proprietary name (INN) or common name. ocrelizumab. Therapeutic area (MeSH). Multiple Sclerosis. Read More

OCREVUS ® (ocrelizumab) is a therapeutic monoclonal antibody that represents a different scientific approach to treating MS. It targets a type of immune cell ... Read More